Tactical Biomedical Technologies*
Abstract
*Previously funded in PE 0602715E, Project MBT-02 The Tactical Biomedical Technologies thrust will develop new approaches to deliver life-saving medical care on the battlefield. Uncontrolled blood loss is the leading cause of preventable death for soldiers on the battlefield. While immediate control of hemorrhage is the most effective strategy for treating combat casualties and saving lives, currently no method other than surgical intervention can effectively treat intracavitary bleeding. A focus in this thrust is the co-development of a materials-based agent(s) and delivery mechanism capable of damaged tissue-targeted hemostasis and wound control. This system will effectively treat compressible and non-compressible wounds regardless of geometry or location. Additionally, rapid response to emerging biological threats on the battlefield is impacted by logistical delays of delivering the necessary therapeutics. Creating a "pharmacy on demand" will enable far-forward medical providers to manufacture and produce small molecule drugs and biologics in order to ensure that the therapeutics are available when they need them. This project will also develop new algorithms, protocols, and methods to allow registration and comparison of disparate sources of data in biology (across species, experimental systems, hierarchies and populations).
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2013
- Source ID
- 81c34aaebff5e1f83451235e1d7e5dc1
Related Documents
- Root: BIOMEDICAL TECHNOLOGY